Skip to main content

KBC Group NV

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1411133 Brussels, C9

Position in REGN

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$29,725,778
+$228,767 QoQ
Shares Held
38,473
+0.7% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

KBC Group NV holds $172,610,851 across 111 Biotechnology names. REGN ranks #2 (17.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
38,473 $29,725,778

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,725,778 38,473
2025-12-31 $29,497,011 38,215
2025-09-30 $18,702,224 33,262
2025-06-30 $19,200,300 36,572
2025-03-31 $94,779,330 149,440
2024-12-31 $97,337,756 136,647
2024-09-30 $36,214,166 34,449
2024-06-30 $36,199,574 34,442
2024-03-31 $32,969,131 34,254
2023-12-31 $57,551,708 65,527
2023-09-30 $54,796,790 66,585
2023-06-30 $51,242,679 71,315
2023-03-31 $62,320,382 75,846
2022-12-31 $78,699,406 109,079
2022-09-30 $42,765,049 62,080
2022-06-30 $49,380,043 83,535
2022-03-31 $60,589,330 86,752
2021-12-31 $146,667,993 232,246
2021-09-30 $87,349,865 144,337
2021-06-30 $73,638,471 131,841
2021-03-31 $69,889,401 147,714
2020-12-31 $69,699,728 144,273
2020-09-30 $72,105,821 128,811
2020-06-30 $42,536,048 68,205
2020-03-31 $15,802,527 32,363